Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness

Immunology Letters

Volumn 143, Issue 2, 2012, Pages 170-176

  Choi, Je Min ^a,b   Sohn, Jung Ho ^a,b,c   Park, Tae Yoon ^d,e   Park, Jung Won ^c   Lee, Sang Kyou ^d,e  

^a Hanyang University   (South Korea)

^b Hanyang Biomedical Research Institute   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University   (South Korea)

^e National Creative Research Initiatives Center for Inflammatory Response Modulation   (South Korea)

Author keywords

Asthma; Cell permeable peptide; NFAT; VIVIT

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA GALACTOSIDASE; ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2; OVALBUMIN; PEPTIDE; SIM 2 VIVIT PEPTIDE; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LUNG INFILTRATE; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; OLIGOPEPTIDES; T-LYMPHOCYTES;

EID: 84862792153     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.01.016     Document Type: Article

References (31)

1. Jain J., McCaffrey P.G., Miner Z., Kerppola T.K., Lambert J.N., Verdine G.L., et al. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993, 365:352-355.
2. McCaffrey P.G., Luo C., Kerppola T.K., Jain J., Badalian T.M., Ho A.M., et al. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 1993, 262:750-754.
3. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
4. Naesens M., Kuypers D.R., Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009, 4:481-508.
5. Aramburu J., Yaffe M.B., Lopez-Rodriguez C., Cantley L.C., Hogan P.G., Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999, 285:2129-2133.
6. Kiani A., Garcia-Cozar F.J., Habermann I., Laforsch S., Aebischer T., Ehninger G., et al. Regulation of interferon-gamma gene expression by nuclear factor of activated T cells. Blood 2001, 98:1480-1488.
7. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A., et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998, 4:1449-1452.
8. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
9. Elisabetta Z., Roberto M., Miuzzo M., Cavallarin N., Di Paolo M.L., Sandona D., et al. TAT-mediated aequorin transduction: an alternative approach for effective calcium measurements in plant cells. Plant Cell Physiol 2011.
10. Snyder E.L., Meade B.R., Saenz C.C., Dowdy S.F. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. PLoS Biol 2004, 2:E36.
11. Eguchi A., Meade B.R., Chang Y.C., Fredrickson C.T., Willert K., Puri N., et al. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat Biotechnol 2009, 27:567-571.
12. Pei L., Li S., Wang M., Diwan M., Anisman H., Fletcher P.J., et al. Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 2010, 16:1393-1395.
13. Perez F., Joliot A., Bloch-Gallego E., Zahraoui A., Triller A., Prochiantz A. Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J Cell Sci 1992, 102(Pt 4):717-722.
14. Stroh C., Held J., Samraj A.K., Schulze-Osthoff K. Specific inhibition of transcription factor NF-kappaB through intracellular protein delivery of I kappaBalpha by the Herpes virus protein VP22. Oncogene 2003, 22:5367-5373.
15. Lee K.C., Hamstra D.A., Bullarayasamudram S., Bhojani M.S., Moffat B.A., Dornfeld K.J., et al. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit. Gene Ther 2006, 13:127-137.
16. Noguchi H., Matsushita M., Okitsu T., Moriwaki A., Tomizawa K., Kang S., et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004, 10:305-309.
17. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002, 277:2437-2443.
18. Duchardt F., Ruttekolk I.R., Verdurmen W.P., Lortat-Jacob H., Burck J., Hufnagel H., et al. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J Biol Chem 2009, 284:36099-36108.
19. De Coupade C., Fittipaldi A., Chagnas V., Michel M., Carlier S., Tasciotti E., et al. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem J 2005, 390:407-418.
20. Choi J.M., Ahn M.H., Chae W.J., Jung Y.G., Park J.C., Song H.M., et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006, 12:574-579.
21. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Asthma Vignola A.M. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720-1745.
22. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999, 402:B5-B11.
23. Ngoc P.L., Gold D.R., Tzianabos A.O., Weiss S.T., Celedon J.C. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005, 5:161-166.
24. Lloyd C.M., Hessel E.M. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol 2010, 10:838-848.
25. Park J.W., Min H.J., Sohn J.H., Kim J.Y., Hong J.H., Sigrist K.S., et al. Restoration of T-box-containing protein expressed in T cells protects against allergen-induced asthma. J Allergy Clin Immunol 2009, 123:479-485.
26. Choi J.M., Shin J.H., Sohn M.H., Harding M.J., Park J.H., Tobiasova Z., et al. Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci USA 2010, 107:18575-18580.
27. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004, 10:310-315.
28. Platz K.P., Mueller A.R., Blumhardt G., Bachmann S., Bechstein W.O., Kahl A., et al. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994, 58:170-178.
29. Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999, 397:530-534.
30. Stone K.D., Prussin C., Metcalfe D.D. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010, 125:S73-S80.
31. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005, 5:472-484.